REVIA NALTREXONE HCI Trademark
Trademark Overview
On Thursday, October 24, 1996, a trademark application was filed for REVIA NALTREXONE HCI with the United States Patent and Trademark Office. The USPTO has given the REVIA NALTREXONE HCI trademark a serial number of 75187094. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, March 12, 2005. This trademark is owned by DuPont Merck Pharmaceutical Company, The. The REVIA NALTREXONE HCI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
providing information and brochures to physicians and healthcare personnel to assist in counseling patients as part of a comprehensive treatment program for alcohol dependence
General Information
| Serial Number | 75187094 |
| Word Mark | REVIA NALTREXONE HCI |
| Filing Date | Thursday, October 24, 1996 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Saturday, March 12, 2005 |
| Registration Number | 2163346 |
| Registration Date | Tuesday, June 9, 1998 |
| Mark Drawing | 3T17 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 17, 1998 |
Trademark Statements
| Disclaimer with Predetermined Text | "NALTREXONE HCI" |
| Description of Mark | The mark consists of a sphere superimposed on a diamond shaped background and includes Applicant's registered trademark "REVIA", No. 1,945,277, and the word "NALTREXONE HCI". |
| Goods and Services | providing information and brochures to physicians and healthcare personnel to assist in counseling patients as part of a comprehensive treatment program for alcohol dependence |
| Lining/Stippling Statement | The drawing is lined for the colors green and brown. The stippling is for shading purposes only and does not indicate color. |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Saturday, March 12, 2005 |
| Primary Code | 042 |
| First Use Anywhere Date | Sunday, March 12, 1995 |
| First Use In Commerce Date | Monday, March 13, 1995 |
Trademark Owner History
| Party Name | DuPont Merck Pharmaceutical Company, The |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 02 - Partnership |
| Address | Wilmington, DE 198072802 |
| Party Name | DuPont Merck Pharmaceutical Company, The |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 02 - Partnership |
| Address | Wilmington, DE 198072802 |
| Party Name | DuPont Merck Pharmaceutical Company, The |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 02 - Partnership |
| Address | Wilmington, DE 198072802 |
Trademark Events
| Event Date | Event Description |
| Saturday, March 12, 2005 | CANCELLED SEC. 8 (6-YR) |
| Wednesday, July 24, 2002 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, June 9, 1998 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 17, 1998 | PUBLISHED FOR OPPOSITION |
| Friday, February 13, 1998 | NOTICE OF PUBLICATION |
| Monday, July 14, 1997 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, June 30, 1997 | ASSIGNED TO EXAMINER |
| Monday, June 30, 1997 | ASSIGNED TO EXAMINER |
